HMGCR is necessary for the tumorigenecity of esophageal squamous cell carcinoma and is regulated by Myc

Tumor Biology

Volumn 35, Issue 5, 2014, Pages 4123-4129

  Zhong, Chenxi ^a   Fan, Limin ^a   Yao, Feng ^a   Shi, Jianxin ^a   Fang, Wentao ^a   Zhao, Heng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Cell growth; Cell migration; ESCC; HMGCR; Myc

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HMGCR PROTEIN, HUMAN; MEVALONIC ACID; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CANCER GROWTH; CARCINOGENICITY; CELL GROWTH; CELL MIGRATION; COLONY FORMATION; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UPREGULATION; CELL MOTION; CELL PROLIFERATION; ESOPHAGUS TUMOR; METABOLISM; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENES, MYC; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; MEVALONIC ACID;

EID: 84902991536     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1539-8     Document Type: Article

References (18)

1. Toh Y, Oki E, Ohgaki K, et al. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis. Int J Clin Oncol. 2010;15:135-44.
2. Zhou ZQ, Cao WH, Xie JJ, et al. Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma. BMC Cancer. 2009;9:291-7.
3. Zhu YH, Fu L, Chen LL, et al. Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma. Cancer Res. 2013;73(7):2298-309.
4. Wang XJ, Zheng YL, Fan QX, et al. RNAi-induced K-Ras gene silencing suppresses growth of EC9706 cells and enhances chemotherapy sensitivity of esophageal cancer. APJCP. 2012;13(12):6517-21.
5. Deberardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7:11-20.
6. Bassam AR, Ian N, Ka FL, et al. A novel statin-mediated "prenylation block-and-release" assay provides insight into the membrane targeting mechanisms of small GTPases. BBRC. 2010;397:34-41.
7. Davidson MH. Safety profiles for the HMG CoA reductase inhibitors: treatment and trust. Drugs. 2001;61:197-206. (Pubitemid 32210196)
8. Cauley JA. Statin use and breast cancer: prospective results from the Women's Health Initiative. J Natl Cancer Inst. 2006;98:700-7. (Pubitemid 43821787)
9. Shimano H. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res. 2001;40:439-52. (Pubitemid 32929966)
10. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997;89:331-40. (Pubitemid 27220877)
11. Hua X, Wu J, Goldstein JL, Brown MS, Hobbs HH. Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13. Genomics. 1995;25:667-73.
12. Shimano H, Shimomura I, Hammer RE, et al. Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. J Clin Invest. 1997;100:2115-24. (Pubitemid 27459368)
13. Shi J, Zhu J, Zhao H, Zhong C, Xu Z, Yao F. Mevalonate pathway is a therapeutic target in esophageal squamous cell carcinoma. Tumour Biol. 2012;34(1):429-35.
14. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007;7:763-77. (Pubitemid 47469806)
15. Yamashita T, Honda M, Takatori H, Nishino R, Minato H, et al. Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma. J Hepatol. 2009;50:100-10.
16. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature. 1990;343:425-30.
17. Jackson SM, Ericsson J, Edwards PA. Signaling molecules derived from the cholesterol biosynthetic pathway. Subcell Biochem. 1997;28:1-21.
18. Cao ZW, Hua FM, David I, et al. Myc phosphorylation, activation and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase. Cancer Research. 2011;71:2286-97.